2022
Adjusting Barcelona Clinic Liver Cancer Staging System to the Evolving Landscape of Hepatocellular Carcinoma: A Look to the Future
Strazzabosco M, Cabibbo G, Colombo M. Adjusting Barcelona Clinic Liver Cancer Staging System to the Evolving Landscape of Hepatocellular Carcinoma: A Look to the Future. Gastroenterology 2022, 162: 2106-2108. PMID: 35122767, DOI: 10.1053/j.gastro.2022.01.035.Peer-Reviewed Original Research
2019
Modeling of implementation of the new Organ Procurement and Transplantation Network/United Network for Organ Sharing policy for patients with hepatocellular carcinoma
Kokabi N, Nezami N, Xing M, Ludwig JM, Strazzabosco M, Kim HS. Modeling of implementation of the new Organ Procurement and Transplantation Network/United Network for Organ Sharing policy for patients with hepatocellular carcinoma. Journal Of Comparative Effectiveness Research 2019, 8: 993-1002. PMID: 31512955, DOI: 10.2217/cer-2019-0076.Peer-Reviewed Original ResearchConceptsTransplantation Network/United NetworkOrgan Sharing (UNOS) policyUnited NetworkNew Organ ProcurementHepatocellular carcinomaOrgan procurementOrthotopic liver transplantation outcomesLiver transplantation outcomesOrgan Sharing databaseOverall survivalPatient characteristicsSharing databaseTransplantation outcomesPatientsCarcinomaAMPTransplantationGroup
2017
Clinical presentation and outcomes of hepatocellular carcinoma in elderly patients referred to a tertiary center: 5-Years experience
Okolicsanyi S, Bonato G, Pontecorvi V, Ciaccio A, Gemma M, Strazzabosco M. Clinical presentation and outcomes of hepatocellular carcinoma in elderly patients referred to a tertiary center: 5-Years experience. Digestive And Liver Disease 2017, 49: e23. DOI: 10.1016/j.dld.2017.01.048.Peer-Reviewed Original ResearchSAT-106 Early changes in perfusion-computed tomography scan parameters as a marker of improved outcomes in patients with hepatocellular carcinoma treated with Sorafenib
Okolicsanyi S, Ippolito D, Querques G, Bonato G, Pontecorvi V, Corso R, Invernizzi P, Strazzabosco M. SAT-106 Early changes in perfusion-computed tomography scan parameters as a marker of improved outcomes in patients with hepatocellular carcinoma treated with Sorafenib. Journal Of Hepatology 2017, 66: s632. DOI: 10.1016/s0168-8278(17)31712-9.Peer-Reviewed Original Research
2013
Nonsteroidal anti‐inflammatory drug use, chronic liver disease, and hepatocellular carcinoma: The egg of columbus or another illusion?
Kim AK, Dziura J, Strazzabosco M. Nonsteroidal anti‐inflammatory drug use, chronic liver disease, and hepatocellular carcinoma: The egg of columbus or another illusion? Hepatology 2013, 58: 819-821. PMID: 23703812, DOI: 10.1002/hep.26498.Peer-Reviewed Original Research
2011
Impact of HCV Infection on Graft Survival After Liver Transplantation for Hepatocellular Carcinoma in Compensated Cirrhosis: The Liver Match Cohort Study
Angelico M, Cillo U, Fagiuoli S, Strazzabosco M, Gasbarrini A, Romagnoli R, Nardi A. Impact of HCV Infection on Graft Survival After Liver Transplantation for Hepatocellular Carcinoma in Compensated Cirrhosis: The Liver Match Cohort Study. Gastroenterology 2011, 140: s-901. DOI: 10.1016/s0016-5085(11)63738-4.Peer-Reviewed Original Research
2007
[272] COMPARISON OF C.L.I.P., T.N.M. AND B.C.L.C. STAGING SYSTEMS FOR HEPATOCELLULAR CARCINOMA (HCC) IN A COHORT OF PROSPECTIVELY FOLLOWED HCC PATIENTS
De Giorgio M, Bezzo R, Govindarajulu U, Dziura J, Luca M, Verga G, Pinelli D, Colledan M, Fagiuoli S, Strazzabosco M. [272] COMPARISON OF C.L.I.P., T.N.M. AND B.C.L.C. STAGING SYSTEMS FOR HEPATOCELLULAR CARCINOMA (HCC) IN A COHORT OF PROSPECTIVELY FOLLOWED HCC PATIENTS. Journal Of Hepatology 2007, 46: s109. DOI: 10.1016/s0168-8278(07)61870-4.Peer-Reviewed Original Research